BIRMINGHAM, Ala. and EXTON, Pa., Nov. 9 /PRNewswire-USNewswire/ -- Southern Research Institute and Absorption Systems, LP today announced that they have expanded their joint marketing agreement to allow Absorption Systems to represent Southern Research in European biotechnology and pharmaceutical markets. Ten months ago, the two organizations announced that they had signed a joint marketing agreement to collaborate in marketing contract research services in the areas of toxicology and bioanalytical services to biotechnology and pharmaceutical clients in the U.S.
The agreement expands this partnership so Absorption Systems will provide marketing and sales representation of Southern Research in Europe. Both companies will continue to provide critical preclinical contract research support to the biotechnology and pharmaceutical industries. Financial terms of the agreement were not announced.
“Our international business has expanded dramatically in the past 18 months, so this agreement with Absorption Systems will allow us to enhance our support to those clients, while continuing to expand our geographic reach,” said Chaarles G. Fogelgren, director of Business Operations for the Drug Development Division at Southern Research.
“We are excited about expanding our relationship with Southern Research. Adding their capabilities in toxicology, cancer efficacy and anti-infectives to our capabilities in ADME and bioanalysis will provide a better outsourcing solution for our clients,” said Patrick Dentinger, president and CEO of Absorption Systems.
The European sales and marketing representation also signals an expansion of Southern Research’s dedicated sales force. In the past year, Southern Research has established a U.S.-based geographic sales force (http://www.southernresearch.org/bd-territories.html) and is moving to expand upon this success.
About Absorption Systems, LP
Founded in 1996, Absorption Systems, LP (ASLP) focuses on performing assays that can predict the Absorption, Distribution, Metabolism, and Excretion (ADME) of small molecules using a variety of in vitro, in situ, and in vivo models. ASLP supports these assays with state-of-the-art bioanalytical capabilities and preclinical formulation services. For more information, visit http://www.absorption.com.
About Southern Research Institute
Southern Research Institute is a not-for-profit organization that conducts basic and applied research in the areas of preclinical drug discovery and development. To date, Southern Research has discovered a record six cancer drugs that have received FDA-approval, with another six compounds currently in late-stage preclinical development or clinical trials. Southern Research has evaluated 50 percent of all other FDA-approved cancer drugs currently on the market. For more information, please visit http://www.SouthernResearch.org.
Media Contacts
Rhonda Jung 205-581-2317
Southern Research
jung@southernresearch.org
Risa Burgess 781-684-0770
Schwartz Communications
southern@schwartz-pr.com
CONTACT: Rhonda Jung of the Southern Research Institute, +1-205-581-2317,
jung@southernresearch.org, Risa Burgess of Schwartz Communications,
+1-781-684-0770, southern@schwartz-pr.com
Web site: http://www.absorption.com/
http://www.southernresearch.org/
http://www.southernresearch.org/bd-territories.html/
